Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation

Cong Zhang; Cui-Lian Luo; Guan-Sheng Shang; De-Xiong Jiang; Qi Song

doi:10.12659/MSM.931630

17 December 2021: Animal Study

Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation

Cong Zhang ^1ABF* , Cui-Lian Luo ^1BCD* , Guan-Sheng Shang ^1DE , De-Xiong Jiang ^1BF , Qi Song ^2AG*

DOI: 10.12659/MSM.931630

Med Sci Monit 2021; 27:e931630

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 2 Exponential effect curves of the combination of fluorouracil (5-FU) and galangin in Het-1A, Eca109, and OE19 cells for 48- or 72-h treatment. Each point is related to a combination index (CI) value of different combined treatment effects.

Back to the Article

Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation

Your Privacy